Business Wire

NV-ISACA

15.10.2018 15:37:05 CEST | Business Wire | Press release

Share
9 in 10 Enterprises Report Gaps Between the Cybersecurity Culture They Have and the One They Want

With cybersecurity threats continuing to escalate worldwide, the ISACA/CMMI Institute Cybersecurity Culture Report found that just 5 percent of employees think their organization’s cybersecurity culture is as advanced as it needs to be to protect their business from internal and external threats. More than 4,800 business and technology professionals shared their insights in the global research study, conducted via online polling in June 2018. Results were released today at ISACA’s CSX North America cybersecurity conference in Las Vegas.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181015005149/en/

Cybersecurity culture is a workplace culture in which security awareness and behaviors are integrated into everyone’s daily operations, as well as an executive leadership priority. In a threat-ripe environment, an effective cybersecurity culture can help employees understand their roles and responsibilities in keeping their organizations safe and customer data secure. However, just 34 percent of respondents say they understand their role in their organizations’ cyber culture.

Companies must take an all-hands-on-deck approach to counter cyberattack threats, the report summarizes.

“Enlisting the entire workforce to mitigate an enterprise’s cyber risk is an emerging practice,” says Doug Grindstaff II, SVP of Cybersecurity Solutions at CMMI Institute . “We are hearing a lot of feedback about how organizations can move the needle on employee involvement. It’s challenging, but organizations are rightly concerned by the growing sophistication of cyberattacks.”

Widespread employee involvement correlates strongly with the minority of organizations that have achieved strong satisfaction with their cybersecurity culture. Nine in ten employees (92 percent) at these organizations say that their C-level executives share an excellent understanding of the underlying issues, which may be why they loop-in their employees so well; 84 percent of employees at these organizations say they understand their role in cybersecurity.

Other critical findings include:

  • Many organizations lack the first—and all-important—step toward a cybersecurity culture: 42 percent of organizations do not have an outlined cybersecurity culture management plan or policy.
  • Aligning the entire workforce with the organization’s cybersecurity policies requires significant capital: Organizations that report a significant gap between their current and desired cybersecurity culture are spending just 19 percent of their annual cybersecurity budget on training and tools; organizations that believe their cybersecurity culture is where it is supposed to be are spending more than twice as much (43 percent).

“A key motivator for organizations delaying investing in their cybersecurity cultures is a lack of awareness about the attempted threats and ongoing risks, as well as a lack of awareness about the assets at risk to cybersecurity threats,” said Rob Clyde, NACD Board Leadership Fellow and ISACA Board Chair. “However, individuals tend to underestimate the potential damage and overestimate technology’s ability to limit such incidents. Doing so puts their organizations at serious risk.”

To view the research, visit www.isaca.org/cybersecurity-culture-study .

About ISACA

Nearing its 50th year, ISACA ® (isaca.org ) is a global association helping individuals and enterprises achieve the positive potential of technology. ISACA equips professionals with the knowledge, credentials, education and community to advance their careers and transform their organizations.

Twitter: www.twitter.com/ISACANews

About CMMI ® Institute

A subsidiary of ISACA Enterprises, CMMI Institute (cmmiinstitute.com ) is the global leader in the advancement of best practices in people, process and technology. The Institute provides the tools and support for organizations to benchmark their capabilities and maturity by comparing their operations to best practices and identifying performance gaps.

Twitter: https://twitter.com/CMMI_Institute

Contact:

ISACA Emily Van Camp, +1.847.385.7223 evcamp@isaca.org or Kristen Kessinger, +1.847.660.5512 kkessinger@isaca.org

Link:

ClickThru

Social Media:

https://www.facebook.com/ISACAHQ

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye